Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 727-733

  Hemby, S E ^a,d   Lucki, I ^b   Gatto, G ^e   Singh, A ^b   Thornley, C ^a   Matasi, J ^c   Kong, N ^c   Smith, J E ^a   Davies, H M L ^c   Dworkin, S I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE; FLUOXETINE; MONOAMINE; SEROTONIN; TROPANE DERIVATIVE; VANOXERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DEPRESSION; DOPAMINE BRAIN LEVEL; DRUG EFFICACY; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN UPTAKE; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; CARRIER PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; LOCOMOTION; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STEREOTYPED BEHAVIOR; SWIMMING; TROPANES;

EID: 8544244894     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ASBERG, M. AND MARTENSSON, B.: Serotonin selective antidepressant drugs: Past, present, future. Clin. Neuropharm. 16: S32-44, 1993.
2. BALDESSARINI, R. J.: Drugs and the treatment of psychiatric disorders: Depression and mania. In The Pharmacological Basis of Therapeutics, 9th ed., ed. by J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. Ruddon and A. G. Gilman, pp. 431-459, McGraw-Hill, New York, 1996.
3. BENNETT, B., WICHEMS, C. H., HOLLINGSWORTH, C. K., DAVIES, H. M. L., THORNLEY, C., SEXTON, T., CHILDERS, S. R.: Novel 2-substituted cocaine analogs: Uptake and ligand binding studies at dopamine serotonin and norepinephrine transport sites in the rat brain. J. Pharmacol. Exp. Ther. 272: 1176-1186, 1995.
4. BORSINI, F.: Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 19: 377-95, 1995.
5. BORSINI, F. AND MELI, A.: Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94: 147-160, 1988.
6. BROWN, A. S. AND GERSHON, S.: Dopamine and depression. J. Neural Transm. 91: 75-109, 1993.
7. CACCIA, S., CAPPI, M., FRACASSO, C. AND GARATTINI, S.: Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology 100: 509-514, 1990.
8. DACKIS, C. A. AND GOLD, M. S.: New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci. Biobehav. Rev. 9: 469-477, 1985.
9. DAVIES, H. M. L., KUHN, L., THORNLEY, C., MATASI, J. J., SEXTON T. AND CHILDERS, S. R.: Synthesis of 3β-aryl-8-azabicyclo[3.2.1]octanes with high binding affinities and selectivities for the serotonin transport site. J. Med. Chem. 39: 2554-2558, 1996.
10. DAVIES, H. M. L., SAIKALI, E., HUBY, N. J. S., GILLIATT, V. J., MATASI, J. J., SEXTON, T. AND CHILDERS, S. R.: Synthesis of 2β-acyl-3β-aryl-8-azabicyelo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex. J. Med. Chem. 37: 1262-1268, 1994.
11. DAVIES, H. M. L., SAIKALI, E., SEXTON, T. AND CHILDERS, S. R.: Novel 2-substituted cocaine analogs: Binding properties at dopamine transport sites in rat striatum. Eur. J. Pharmacol. 244: 93-97, 1993.
12. DAVIES, H. M. L., SAIKALI, E. AND YOUNG, W. B.: Synthesis of (±)-ferruginine and (±)-anhydroecognine methyl ester by a tandem cyclopropanation/Cope arrangement. J. Org. Chem. 56: 5696-5700, 1991.
13. DETKE, M. J., RICKELS, M. AND LUCKI, I.: Active behaviors in the rat FST differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 119: 47-54, 1995.
14. ELLINWOOD, E. H., JR., BALSTER, R. T.: Rating the behavioral effects of amphetamine. Eur. J. Pharmacol. 28: 35-41, 1974.
15. HEMBY, S. E., CO, C., REBOUSSIN, D., DAVIES, H. M. L., DWORKIN, S. I. AND SMITH, J. E.: Comparison of a novel tropane analog of cocaine, 2β-propanoyl-3β-(4-tolyl) tropane (PTT) with cocaine HCl in rats: Nucleus accumbens extracellular dopamine concentration and motor activity. J. Pharmacol. Exp. Ther. 273: 656-666, 1995.
16. HEMBY, S. E., JOHNSON, B. A. AND DWORKIN, S. I.: Neurobiological basis of drug reinforcement. In Drug Addiction and Its Treatment: Nexus of Neuroscience and Behavior, ed. by B. A. Johnson and J. D. Roache, pp. 137-169, Raven Press, New York, 1997.
17. NETER, J., WASSERMAN, W. AND KUTNER, M. J.: Applied Linear Statistical Models: Regression, Analysis of Variance, and Experimental Designs, 2nd ed., Irwin, Homewood, IL, 1985.
18. PORSOLT, R. D., ANTON, G., BLAVET, N. AND JALFRE, M.: Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47: 379-391, 1978a.
19. PORSOLT, R. D., BERTIN, A. AND JALFEE, M.: 'Behavioral despair' in rats and mice: Strain differences and the effect of imipramine. Eur. J. Pharmacol. 51: 291-294, 1978b.
20. PORSOLT, R. D. AND LENEGRE, A.: Behavioral models of depression. In Experimental Approaches to Anxiety and Depression, ed. by J. M. Elliot, D. J. Heal and C. A. Marsden, pp. 73-85, John Wiley and Sons, New York, 1992.